Novo Nordisk open to New York listing upgrade, CEO Doustdar tells FT

3

Sept 23 (Reuters) – Novo Nordisk is open to the idea of upgrading its New York listing as part of efforts to raise the Danish weight-loss drugmaker's profile in the country, its chief executive told

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)